Sacubitril Hemicalcium Salt ODM Manufacturer Guide 2026

Ced9b441666ca1b89e5e10b44ec34c4a
0 0
Read Time:5 Minute, 42 Second

Sourcing a dependable Sacubitril hemicalcium salt ODM manufacturer has become a pressing priority for generic formulation developers, API process teams and CDMO partners as the global fine chemical and pharmaceutical intermediate market evolves. With relevant patents for Sacubitril Valsartan Sodium (LCZ696) having expired in the US in July 2023 and the China compound patent due to expire in 2026, many chemical developers and R&D institutions are entering a window for new route exploration and raw material qualification.

This market shift has lifted demand for qualified, stable and cost-competitive suppliers of Sacubitril Calcium (CAS 1369773-39-6), an advanced synthetic intermediate applied in the preparation of the Sacubitril-Valsartan co-crystal and for new chemical entity route research.

Why Supplier Selection Matters for Sacubitril Calcium

Buyers evaluating a Sacubitril hemicalcium salt supplier typically face several interlocking challenges: extended lead times for high-end specialty intermediates, volatile raw material pricing, inconsistent batch quality that disrupts downstream synthesis, fragmented sourcing across multiple vendors that raises procurement overhead, and difficulty matching custom process parameters for this niche chiral intermediate category. For teams advancing pre-qualification work and inventory planning ahead of patent expiry, these sourcing pain points directly translate into project schedule risk and higher overall R&D costs.

Shandong Tianming Pharmaceutical Group’s Positioning

Shandong Tianming Pharmaceutical Group, operating under the brand name Tianming Pharma (also known as Tianming Pharmaceutical), is an R&D-focused enterprise specializing in pharmaceutical raw materials and fine chemical intermediates with an integrated R&D and production model. The company supplies intermediates, custom synthesis and CMO/CDMO development services for global chemical and pharmaceutical R&D clients. Its Sacubitril-Valsartan intermediate series, alongside the full-chain intermediates for Orforglipron, form one of its core product portfolios.

Full-Chain Coverage from Starting Material to Advanced Intermediates

A defining advantage of Tianming Pharmaceutical’s offering is its complete upstream-to-downstream product ladder. Instead of supplying a single intermediate and leaving customers to coordinate with multiple separate vendors, the team provides a connected product portfolio covering chiral starting materials, key synthetic intermediates and advanced building blocks for the Sacubitril synthetic pathway.

  • Sacubitril Valsartan Sodium co-crystal intermediate (CAS 936623-90-4): high-purity substance for synthetic route study and formulation development
  • Sacubitril Calcium (CAS 1369773-39-6): advanced intermediate for co-crystal synthesis and alternative NCE route exploration
  • Chiral starting material (2R)-2-[1,1'-biphenyl]-4-yl-1-(hydroxymethyl)ethyl]carbamic acid tert-butyl ester (CAS 142612-95-01): core chiral precursor for Sacubitril synthesis
  • Ethoxycarbonylmethylene triphenylphosphorane (CAS 571-73-73): Wittig reagent used in olefination reaction steps
  • Unsaturated coupling intermediate (CAS 101234-48-8): intermediate generated after Wittig coupling reaction
  • Saturated chiral hydrogenation intermediate (CAS 101234-50-2): hydrogenated chiral intermediate
  • Deprotected chiral amine intermediate (CAS 149690-12-0): deprotected amine building block

Whether clients only require Sacubitril Calcium as a standalone intermediate or seek full synthetic pathway support from one supplier, Tianming Pharmaceutical helps reduce coordination costs and communication risks associated with multi-supplier sourcing.

Ced9b441666ca1b89e5e10b44ec34c4a

Quality Control Framework for Registration-Grade Documentation

For any Sacubitril hemicalcium salt ODM manufacturer, consistent quality performance is often a higher priority than unit price. Tianming Pharmaceutical applies registration-oriented quality control standards throughout Sacubitril Calcium production, with strict monitoring of molar ratio, chiral impurities, residual solvents, particle characteristics and crystal form profiles. Internal specifications control individual impurities below 0.1% and chiral purity above 99.5%. The quality system covers raw material incoming inspection, in-process testing and finished product release. Complete COA, analytical methodology documents, impurity profile data and stability study records can be provided to support clients’ global regulatory dossier preparation.

Scale and Flexible Production Infrastructure

The quality assurance framework is backed by flexible, scalable production infrastructure. Tianming Pharmaceutical Group operates three coordinated production subsidiaries: Shandong Sihuan Pharmaceutical Co., Ltd. in Dezhou, Jining Tianming Pharmaceutical Co., Ltd. in Jining, and Guangxi Tianming Pharmaceutical Co., Ltd. in Hechi, with multiple reactor suites and more than 160 reaction vessels in total. Annual combined capacity reaches hundreds of tons, with safety stock arrangements and elastic capacity reserves. This setup supports stable supply from gram-scale lab batches, pilot kilogram runs to commercial ton-scale orders. Clients can advance their development stages without switching suppliers repeatedly.

Independent Process Development and Dedicated Technical Support

Tianming Pharmaceutical has developed its own scalable synthetic routes for the Sacubitril intermediate series, optimized for industrial scale-up and consistent batch performance. In-house QC testing relies on HPLC, GC, mass spectrometry, LC-MS and chiral chromatography instruments. Two R&D centers in Jinan and Nanjing occupy more than 6,000 square meters of laboratory space, equipped with over RMB 40 million of professional analytical and synthesis equipment. Each customer is assigned a dual support team: an account manager plus a technical engineer. Standard technical inquiries receive reference solutions within 2 working hours, while complex technical issues are addressed with formal written reports within 24 hours. Framework and bulk order customers may access on-site technical consultation and periodic follow-up support.

Global Delivery and Cross-Border Logistics Support

Demand for Sacubitril Calcium spans domestic R&D teams and international buyers preparing dossiers for different global markets, so reliable delivery is equally critical to chemical quality. In-stock items are available for shipment within 7–15 working days, covering order confirmation, quality review, packaging and logistics arrangement. Lead times for custom-made orders depend on synthetic complexity, workshop scheduling and raw material availability; expedited production can be arranged for urgent R&D projects. International orders are supported by logistics coordination, customs documentation and trade insurance services. The company’s business footprint covers more than 30 countries and regions across South Asia, Southeast Asia, the Middle East, Central & South America and Africa, alongside domestic coverage across major pharmaceutical clusters in East, North and South China.

Aligned Supply Chain Solutions for Patent Transition Period

For formulation developers tracking the China compound patent expiry timeline, API teams supplying global markets and CDMO partners supporting formulation and scale-up projects, the integrated full-chain intermediate portfolio, registration-ready technical documentation and flexible gram-to-ton supply capacity make Tianming Pharmaceutical Group a suitable upstream partner for this market transition. As related R&D activities expand, teams that lock in stable upstream intermediate supply ahead of key milestones are better positioned to advance their development plans.


Disclaimer

All products mentioned are fine chemical intermediates and building blocks, intended for laboratory research, process development and synthetic route study only. They are not finished drug products and are not for direct clinical use. Reference to existing compound names and CAS numbers is for chemical identification purposes only. Buyers shall independently verify all relevant patent status and regulatory compliance before any commercial application.

Home


Tianming Pharmaceutical Group

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Dfe8c13387f8e21c4cb12f0777748ebf
Previous post Microbial CRDMO Enables 2000L Fermentation Scale-Up Yaohai
2f7146a1d21dfbdc33a7a7199386eb7b
Next post Large Speaker or Portable PA for Café Acoustic Performances?

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *